Iridex (IRIX) Cash from Operations Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -16.14% |
| Sep 27, 2025 | -36.99% |
| Jun 28, 2025 | 27.53% |
| Mar 29, 2025 | 4.59% |
| Dec 28, 2024 | -45.63% |
| Sep 28, 2024 | -3.70% |
| Jun 29, 2024 | 0.56% |
| Mar 30, 2024 | 15.37% |
| Dec 30, 2023 | 13.75% |
| Sep 30, 2023 | 9.41% |
| Jul 1, 2023 | 13.28% |
| Apr 1, 2023 | -0.84% |
| Dec 31, 2022 | -11.30% |
| Oct 1, 2022 | -2.24% |
| Jul 2, 2022 | -37.66% |
| Apr 2, 2022 | -14.93% |
| Jan 1, 2022 | 103.82% |
| Apr 3, 2021 | 86.38% |
| Mar 28, 2020 | -34.21% |
| Sep 28, 2019 | -32.42% |
| Jun 29, 2019 | -30.28% |
| Mar 30, 2019 | -51.14% |
| Dec 29, 2018 | -28.30% |
| Sep 29, 2018 | -44.16% |
| Jun 30, 2018 | -33.05% |
| Mar 31, 2018 | -46.36% |
| Dec 30, 2017 | -33.80% |
| Sep 30, 2017 | -55.76% |
| Jul 1, 2017 | 28.78% |
| Apr 1, 2017 | -5.48% |
| Dec 31, 2016 | -17.32% |
| Oct 1, 2016 | -27.22% |
| Jul 2, 2016 | 41.81% |
| Apr 2, 2016 | 22.19% |